These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32508359)

  • 21. Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit.
    Wang X; Long Y; Su L; Zhang Q; Shan G; He H
    Front Cell Infect Microbiol; 2022; 12():844134. PubMed ID: 35360102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study.
    Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F
    J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study.
    Gavazzi G; Drevet S; Debray M; Bosson JL; Tidadini F; Paccalin M; de Wazieres B; Celarier T; Bonnefoy M; Vitrat V
    BMC Geriatr; 2022 Dec; 22(1):965. PubMed ID: 36517740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke.
    Ulm L; Hoffmann S; Nabavi D; Hermans M; Mackert BM; Hamilton F; Schmehl I; Jungehuelsing GJ; Montaner J; Bustamante A; Katan M; Hartmann A; Ebmeyer S; Dinter C; Wiemer JC; Hertel S; Meisel C; Anker SD; Meisel A
    Front Neurol; 2017; 8():153. PubMed ID: 28484421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
    Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
    Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Procalcitonin-guided antibiotic treatment in critically ill patients.
    Hohn A; Heising B; Schütte JK; Schroeder O; Schröder S
    Langenbecks Arch Surg; 2017 Feb; 402(1):1-13. PubMed ID: 27283067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of a procalcitonin-guided algorithm for antibiotic therapy in the burn intensive care unit.
    Lavrentieva A; Kontou P; Soulountsi V; Kioumis J; Chrysou O; Bitzani M
    Ann Burns Fire Disasters; 2015 Sep; 28(3):163-70. PubMed ID: 27279801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procalcitonin-guided antibiotic therapy in intensive care unit patients: a systematic review and meta-analysis.
    Huang HB; Peng JM; Weng L; Wang CY; Jiang W; Du B
    Ann Intensive Care; 2017 Nov; 7(1):114. PubMed ID: 29168046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
    Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
    Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
    Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
    JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization.
    Fratoni AJ; Kois AK; Colmerauer JL; Linder KE; Nicolau DP; Kuti JL
    Open Forum Infect Dis; 2022 Sep; 9(9):ofac468. PubMed ID: 36176570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
    Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
    J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
    Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
    Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients.
    Matthaiou DK; Ntani G; Kontogiorgi M; Poulakou G; Armaganidis A; Dimopoulos G
    Intensive Care Med; 2012 Jun; 38(6):940-9. PubMed ID: 22538461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment of sepsis patients].
    Xu XL; Yan FD; Yu JQ; Chen QH; Lin H; Zheng RQ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):343-346. PubMed ID: 28219190
    [No Abstract]   [Full Text] [Related]  

  • 39. Procalcitonin Levels in Critically Ill Children With Status Asthmaticus.
    Samraj RS; Crotty EJ; Wheeler DS
    Pediatr Emerg Care; 2019 Oct; 35(10):671-674. PubMed ID: 31593980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.